Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Hum Hypertens ; 28(9): 535-42, 2014 Sep.
Article de Anglais | MEDLINE | ID: mdl-24430701

RÉSUMÉ

Overweight clusters with high blood pressure (BP), but the independent contribution of both risk factors remains insufficiently documented. In a prospective population study involving 8467 participants (mean age 54.6 years; 47.0% women) randomly recruited from 10 populations, we studied the contribution of body mass index (BMI) to risk over and beyond BP, taking advantage of the superiority of ambulatory over conventional BP. Over 10.6 years (median), 1271 participants (15.0%) died and 1092 (12.9%), 637 (7.5%) and 443 (5.2%) experienced a fatal or nonfatal cardiovascular, cardiac or cerebrovascular event. Adjusted for sex and age, low BMI (<20.7 kg m(-2)) predicted death (hazard ratio (HR) vs average risk, 1.52; P<0.0001) and high BMI (> or = 30.9 kg m(-2)) predicted the cardiovascular end point (HR, 1.27; P=0.006). With adjustments including 24-h systolic BP, these HRs were 1.50 (P<0.001) and 0.98 (P=0.91), respectively. Across quartiles of the BMI distribution, 24-h and nighttime systolic BP predicted every end point (1.13 < or = standardized HR < or = 1.67; 0.046 < or = P<0.0001). The interaction between systolic BP and BMI was nonsignificant (P > or = .22). Excluding smokers removed the contribution of BMI categories to the prediction of mortality. In conclusion, BMI only adds to BP in risk stratification for mortality but not for cardiovascular outcomes. Smoking probably explains the association between increased mortality and low BMI.


Sujet(s)
Surveillance ambulatoire de la pression artérielle , Pression sanguine , Indice de masse corporelle , Hypertension artérielle/diagnostic , Hypertension artérielle/ethnologie , Obésité/diagnostic , Obésité/ethnologie , Adulte , Sujet âgé , Antihypertenseurs/usage thérapeutique , Asie/épidémiologie , Pression sanguine/effets des médicaments et des substances chimiques , Europe/épidémiologie , Femelle , Humains , Hypertension artérielle/traitement médicamenteux , Hypertension artérielle/mortalité , Hypertension artérielle/physiopathologie , Incidence , Mâle , Adulte d'âge moyen , Obésité/mortalité , Obésité/physiopathologie , Valeur prédictive des tests , Pronostic , Études prospectives , Appréciation des risques , Facteurs de risque , Fumer/effets indésirables , Fumer/mortalité , Amérique du Sud/épidémiologie , Facteurs temps
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE